Researchers from US retailer GNC reveal that people on GLP-1 medications have poor diet quality, consume insufficient protein per body weight, and are deficient in fiber, calcium, iron, magnesium, potassium, choline, and vitamins A, C, D, and E. GNC states that its findings can help shape clinical practice guidance, supplement formulations, and education efforts to support the drugs’ long-term success.